Interstitial Lung Disease (ILD)/Pulmonary Fibrosis

image description

Make sure you’re getting the very best treatment for interstitial lung disease (ILD). Choose National Jewish Health, the nation’s leading respiratory hospital, specializing in the care of patients with lung disease. Our doctors have vast experience in treating these rare and complex conditions, and will implement a detailed diagnosis and care plan based on the latest ILD innovations.

Our ILD Program offers:

  • New research-based treatment approaches
  • Familial Pulmonary Fibrosis Genetic Counseling Program
  • Pulmonary Fibrosis Support Group
  • Autoimmune Lung Center

As a Specialized Center of Research for interstitial lung disease (ILD) dedicated and funded by the National Institutes of Health, National Jewish Health has access to the newest research-based ILD treatments. Here, scientists work with our doctors and staff to broaden understanding of the causes of ILD and develop new treatment approaches.

Our Specialists

  • Evans R. Fernández Pérez
    Evans R. Fernández Pérez, MD, MSc
  • Kevin K. Brown
    Kevin K. Brown, MD

Clinical Trials

A Linkage and Association Study in Pulmonary Fibrosis

The purpose of this study is to investigate inherited genetic factors that play a role in the development of familial pulmonary fibrosis and to identify a group of genes that predispose individuals to develop pulmonary fibrosis.  Finding the genes which play a role in pulmonary fibrosis is the first step at developing better methods for early diagnosis and improved treatment for pulmonary fibrosis. The overall hypothesis is that inherited genetic factors predispose individuals to develop pulmonary fibrosis.

The study requires the following:

  • For affected individuals, we confirm your diagnosis by reviewing your medical records. We also ask for a history questionnaire to be filled out and obtain a sample of blood or tissue for genetic studies.
  • Unaffected family members are screened with a questionnaire, and a blood sample is obtained for genetic studies.  Some family members may qualify to undergo high-resolution CT (HRCT) scan for the study.

To be eligible:

The only requirement for this study is to have at least 2 members of your family diagnosed with Idiopathic Pulmonary Fibrosis (IPF).  You may be included in this number.

Learn More

Reasons to Visit National Jewish Health

  • The leading respiratory hospital in the nation and the only one devoted fully to the treatment of respiratory and related illnesses
  • Ranked as one of the top two hospitals in pulmonology every year since U.S. News & World Report included this category in its annual “Best Hospitals” survey
  • Ranked in the top 1 percent of hospitals in the nation by HCAHPS
  • Physicians frequently recognized as among the best in the nation by multiple services, including Best Doctors in America and Castle Connolly
  • Among the top 8 percent of organizations funded for research by the NIH, providing patients access to the latest clinical trials
  • 117-year history of focus on care, research and education serving thousands of patients with lung, heart, immune and related disorders

 

Make an Appointment

Patient Stories

Health Insights & News

Giving Help us care for patients with interstitial lung disease. Ways to Give

#Men are nearly twice as likely as women to suffer from #IPF.

Tweet this
Featured Health Insight

Living with Chronic Lung Disease

Adjusting to an illness is a process and will not happen overnight.

Learn More